RSPH holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 97.79% at a quoted market price (level 1), 2 issuer countries.

RSPH's largest investment is Centene Corp at 2.66% of net assets. Humana Inc and UnitedHealth Group Inc follow; the three together are 7.43%. Ten companies are 19.45% of the fund; the other 50 share the rest. Among the 721 equity funds measured here, RSPH behaves like 58.6 holdings against a median of 42.4 — close to the median. Across 27 quarterly filings RSPH has held roughly steady since 2019-10-31 (60.6 then, 56.9 now). Between the 2026-01-31 and 2026-04-30 filings 0 positions were added and 2 dropped; 7.6% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-10-31 and 2026-04-30, RSPH went from behaving like 60.6 equally weighted positions to 56.9 — 6% fewer, while its top ten went from 18.59% to 21.38% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

RSPH's filing lists 62 positions including 2.26% of net assets in securities-lending cash collateral. Counted as filed the fund reads 57.6 effective holdings with a top ten of 19.44%; on its own investments — the figure above — it reads 58.6 with a top ten of 19.45%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

The 15 largest of 60 positions in RSPH's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: RSPH.csv.gz.

Share of RSPH's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of RSPH's own filings, 81 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: RSPH.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $17m was out to 6 borrowers. The largest, STATE STREET BANK & TRUST COMPANY, held 36.6% of it.

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter RSPH has filed, with each borrower: RSPH.json · all funds.

61 positions became 59: 0 added (0.0% of the fund at the later date), 2 dropped (3.5% at the earlier date). Half the sum of all weight changes, a turnover proxy: 7.6%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of RSPH compared this way, as a feed: changes.xml · all funds: filings received.

Gone: Molina Healthcare, Inc. (1.83%), Hologic, Inc. (1.64%).

97.75% equity, 2.25% short-term investment as filed; 97.8% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of RSPH (58.6). Same filings, same arithmetic. Position in this list says nothing about which fund is better.